Blood tumor mutational burden (bTMB) from circulating tumor DNA (ctDNA) as a biomarker for both mutational status and tumor burden in non-small cell lung cancer (NSCLC)

被引：1
|
作者：
Davis, Andrew A. [1 ]
Galvez, Carlos [1 ]
Pan, Alan [1 ]
Mohindra, Nisha [1 ]
Villaflor, Victoria [1 ]
Chae, Young Kwang [1 ]
机构：
[1] Northwestern Univ, Chicago, IL 60611 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-3644
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3644
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Clinical Implications of Circulating Tumor DNA Tumor Mutational Burden (ctDNA TMB) in Non-Small Cell Lung Cancer
    Chae, Young Kwang
    Davis, Andrew A.
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Iams, Wade T.
    Cruz, Marcelo R.
    Tamragouri, Keerthi
    Rhee, Kyunghoon
    Mohindra, Nisha
    Villaflor, Victoria
    Park, Wungki
    Lopes, Gilberto
    Giles, Francis J.
    ONCOLOGIST, 2019, 24 (06): : 820 - 828
  • [2] Blood Tumor Mutational Burden as a Predictive Biomarker in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
    Ma, Yuhui
    Li, Quan
    Du, Yaxi
    Cai, Jingjing
    Chen, Wanlin
    Zhao, Guangqiang
    Liu, Xing
    Li, Hongsheng
    Ma, Luyao
    Huang, Yunchao
    Zhou, Yongchun
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [3] Clinical Potential of Tissue Tumor Mutational Burden (tTMB) and Blood TMB (bTMB) as a Biomarker in Non-Small Cell Lung Cancer
    Zhou, J.
    Zhou, J.
    Chen, X.
    Zhu, Y.
    Fang, L.
    Bao, Z.
    Liu, R.
    Cao, H.
    Sun, W.
    Zhang, T.
    Lin, J.
    Yu, B.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S370 - S370
  • [4] Association of tumor mutational burden with smoking and mutation status in non-small cell lung cancer (NSCLC).
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Mohindra, Nisha Anjali
    Villaflor, Victoria Meucci
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [5] Circulating tumor DNA in advanced prostate cancer: Focus on high blood tumor mutational burden (h-bTMB)
    Guillaume, Z.
    Bayle, A.
    Pobel, C.
    Lacroix, L.
    Vasseur, D.
    Albiges, L.
    Colomba, E.
    Flippot, R.
    Naoun, N.
    Patrikidou, A.
    Goldschmidt, V.
    Vuagnat, P.
    Massard, C.
    Ponce, S.
    Fizazi, K.
    Loriot, Y.
    Baldini, C.
    Italiano, A.
    Bernard-Tessier, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1187 - S1188
  • [6] Non-small cell lung cancer (NSCLC) with higher blood tumor mutational burden (bTMB)/tissueTMB (tTMB) ratio is associated with inferior survival outcome
    Kim, Leeseul
    Park, Jewel
    Oh, Youjin
    Chae, Young Kwang
    CANCER RESEARCH, 2023, 83 (07)
  • [7] The clinical utility of tumor mutational burden in non-small cell lung cancer
    Greillier, Laurent
    Tomasini, Pascale
    Barlesi, Fabrice
    TRANSLATIONAL LUNG CANCER RESEARCH, 2018, 7 (06) : 639 - 646
  • [8] Blood tumor mutational burden and dynamic changes in circulating tumor DNA predict response to pembrolizumab treatment in advanced non-small cell lung cancer
    Stensgaard, Simone
    Thomsen, Astrid
    Helstrup, Sofie
    Meldgaard, Peter
    Sorensen, Boe S.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2023, 12 (05) : 971 - +
  • [9] Comparison of tumor mutational burden (TMB) across tumor tissue and circulating tumor DNA (ctDNA)
    Davis, Andrew A.
    Chae, Young Kwang
    Agte, Sarita
    Pan, Alan
    Simon, Nicholas I.
    Taxter, Timothy J.
    Behdad, Amir
    Carneiro, Benedito A.
    Cristofanilli, Massimo
    Giles, Francis J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Mutational signature analysis in non-small cell lung cancer patients with a high tumor mutational burden
    van den Heuvel, Guus R. M.
    Kroeze, Leonie I.
    Ligtenberg, Marjolijn J. L.
    Grunberg, Katrien
    Jansen, Erik A. M.
    von Rhein, Daniel
    de Voer, Richarda M.
    van den Heuvel, Michel M.
    RESPIRATORY RESEARCH, 2021, 22 (01)
12345